Developing Medical Imaging Drugs and Biological Products
FDA, Food and Drug Administration FDA, Guideline
FDA. Developing Medical Imaging Drugs and Biological Products. Part 3: Design, Analysis, and Interpretation of Clinical Studies. Food and Drug Administration (FDA), Guideline, 2004.
CPMP. Points to consider on the evaluation of diagnostic agents, Committee for Proprietary Medicinal Products (CPMP) of the European Agency for the Evaluation of Medicinal Products (EMEA), CPMP/EWP/1119/98, 2001.
Analysis of blinded reader studies: Correlated proportions for clustered data with repeated measurements
Alexandria, VA: American Statistical Association;
Schwenke C, Kaufmann J. Analysis of blinded reader studies: Correlated proportions for clustered data with repeated measurements. Proceedings of the American Statistical Association, Biometrics section (CD-ROM). Alexandria, VA: American Statistical Association; 2003.
An evaluation of methods for the estimation of sensitivity and specificity of site-specific diagnostic tests
Ahn C. An evaluation of methods for the estimation of sensitivity and specificity of site-specific diagnostic tests. Biometrical Journal 1997; 39: 793-807.
Hypothesis Testing and Confidence Interval Construction in 2 x 2 Tables of Correlated Proportions
May WL, Johnson WD. Hypothesis Testing and Confidence Interval Construction in 2 x 2 Tables of Correlated Proportions. Journal of Biopharmaceutical Statistics 1998; 8: 115-30.
Analysis of proportions from clustered data with missing observations in a matched-pair design
Schwenke C, Nevalainen J. Analysis of proportions from clustered data with missing observations in a matched-pair design. Methods Inf Med 2004; 43: 521-4.